Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2007 1
2008 3
2009 6
2010 2
2012 3
2013 5
2014 6
2015 10
2016 5
2017 2
2018 5
2019 2
2020 11
Text availability
Article attribute
Article type
Publication date

Search Results

52 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean anniewu (2 results)?
A review of systemic medications that may modulate the risk of glaucoma.
Wu A, Khawaja AP, Pasquale LR, Stein JD. Wu A, et al. Eye (Lond). 2020 Jan;34(1):12-28. doi: 10.1038/s41433-019-0603-z. Epub 2019 Oct 8. Eye (Lond). 2020. PMID: 31595027 Review.
PD-1/PD-L1 blockade together with vaccine therapy facilitates effector T-cell infiltration into pancreatic tumors.
Soares KC, Rucki AA, Wu AA, Olino K, Xiao Q, Chai Y, Wamwea A, Bigelow E, Lutz E, Liu L, Yao S, Anders RA, Laheru D, Wolfgang CL, Edil BH, Schulick RD, Jaffee EM, Zheng L. Soares KC, et al. Among authors: wu aa. J Immunother. 2015 Jan;38(1):1-11. doi: 10.1097/CJI.0000000000000062. J Immunother. 2015. PMID: 25415283 Free PMC article.
Combining STING-based neoantigen-targeted vaccine with checkpoint modulators enhances antitumor immunity in murine pancreatic cancer.
Kinkead HL, Hopkins A, Lutz E, Wu AA, Yarchoan M, Cruz K, Woolman S, Vithayathil T, Glickman LH, Ndubaku CO, McWhirter SM, Dubensky TW Jr, Armstrong TD, Jaffee EM, Zaidi N. Kinkead HL, et al. Among authors: wu aa. JCI Insight. 2018 Oct 18;3(20):e122857. doi: 10.1172/jci.insight.122857. JCI Insight. 2018. PMID: 30333318 Free PMC article.
Current Status of Immunotherapies for Treating Pancreatic Cancer.
Wu AA, Jaffee E, Lee V. Wu AA, et al. Curr Oncol Rep. 2019 May 17;21(7):60. doi: 10.1007/s11912-019-0811-5. Curr Oncol Rep. 2019. PMID: 31101991 Review.
Frequency of a diagnosis of glaucoma in individuals who consume coffee, tea and/or soft drinks.
Wu CM, Wu AM, Tseng VL, Yu F, Coleman AL. Wu CM, et al. Among authors: wu am. Br J Ophthalmol. 2018 Aug;102(8):1127-1133. doi: 10.1136/bjophthalmol-2017-310924. Epub 2017 Dec 14. Br J Ophthalmol. 2018. PMID: 29242183
Follicular Dendritic Cell Sarcoma.
Wu A, Pullarkat S. Wu A, et al. Arch Pathol Lab Med. 2016 Feb;140(2):186-90. doi: 10.5858/arpa.2014-0374-RS. Arch Pathol Lab Med. 2016. PMID: 26910224 Free article. Review.
How did we rapidly implement a convalescent plasma program?
Budhai A, Wu AA, Hall L, Strauss D, Paradiso S, Alberigo J, Hillyer CD, Jett B, Tobian AAR, Bloch EM, Sachais BS, Shaz BH. Budhai A, et al. Among authors: wu aa. Transfusion. 2020 Jul;60(7):1348-1355. doi: 10.1111/trf.15910. Epub 2020 Jun 11. Transfusion. 2020. PMID: 32449169 Free PMC article. Review.
Frequency of Bevacizumab and Ranibizumab Injections for Diabetic Macular Edema in Medicare Beneficiaries.
Wu CM, Wu AM, Greenberg PB, Yu F, Lum F, Coleman AL. Wu CM, et al. Among authors: wu am. Ophthalmic Surg Lasers Imaging Retina. 2018 Apr 1;49(4):241-244. doi: 10.3928/23258160-20180329-05. Ophthalmic Surg Lasers Imaging Retina. 2018. PMID: 29664980 Clinical Trial.
Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population.
Klein S, Pekosz A, Park HS, Ursin R, Shapiro J, Benner S, Littlefield K, Kumar S, Naik HM, Betenbaugh M, Shrestha R, Wu A, Hughes R, Burgess I, Caturegli P, Laeyendecker O, Quinn T, Sullivan D, Shoham S, Redd A, Bloch E, Casadevall A, Tobian A. Klein S, et al. Among authors: wu a. medRxiv. 2020 Jun 28:2020.06.26.20139063. doi: 10.1101/2020.06.26.20139063. Preprint. medRxiv. 2020. PMID: 32607519 Free PMC article. Updated.
52 results
Jump to page